COMP <GO>
TRS vs TMO // 10Y YIELD & FRED MACRO BETA
TriMas Corporation (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: TRS 4
— TMO 8
■ METRIC PARITY
LAST: $38.68 (-1.73%) • MKT CAP: $1.39B
macro-sensitivity
—
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
macro-sensitivity
0.94
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TRS VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TRS | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 21.40% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.80% | 9.30% | -4.50 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 32.9x | 30.4x | +2.50 | TMO | /valuation <GO> |
| Free Cash Flow Yield | 8.46% | 2.40% | +6.06 | TRS | /fcf-yield <GO> |
| Operating Margin | 6.40% | 17.40% | -11.00 | TMO | /operating-margins <GO> |
| Net Profit Margin | 18.60% | 15.10% | +3.50 | TRS | /net-margins <GO> |
| Revenue Growth (YoY) | 2.40% | 3.90% | -1.50 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.48% | 0.24% | +0.24 | TRS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.94 | 4.50 | -2.56 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.1 | 62.9 | -22.75 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.7x | 36.3x | -25.60 | TRS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.39B | $262.22B | -$260.83B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TRS REV | TMO REV | TRS GROSS % | TMO GROSS % | TRS FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $645.7M | $44.56B | 21.4% | — | $117.5M | $6.29B |
| FY 2024 | $630.8M | $42.88B | 20.5% | — | $63.8M | $7.27B |
| FY 2023 | $652.1M | $42.86B | — | — | $88.2M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TRS // BETA —
TMO // BETA 0.94